For the quarter ending 2026-03-31, WHWK has $127,231K in assets. $11,056K in debts. $34,790K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 34,790 | 37,568 | 37,931 | 144,936 |
| Accounts receivable, net | - | 0 | 0 | 0 |
| Inventory | - | 0 | 0 | 0 |
| Short-term investments | 88,253 | 108,129 | 124,666 | 32,264 |
| Prepaid expenses and other current assets | 2,505 | 3,316 | 2,439 | 1,471 |
| Total current assets | 125,548 | 149,013 | 165,036 | 178,671 |
| Property and equipment, gross | 377 | 377 | 377 | - |
| Accumulated depreciation | 375 | 374 | 373 | - |
| Property and equipment, net | 2 | 3 | 4 | 9 |
| Operating lease right-of-use assets | - | 0 | 0 | 0 |
| Other assets | 1,681 | 1,814 | 1,977 | 2,142 |
| Total assets | 127,231 | 150,830 | 167,017 | 180,822 |
| Operating lease liabilities, current portion | - | 0 | 0 | 0 |
| Accounts payable | 1,745 | 917 | 1,633 | 3,339 |
| Accrued liabilities | 9,311 | 13,602 | 8,216 | 5,417 |
| Total current liabilities | 11,056 | 14,519 | 9,849 | 8,756 |
| Operating lease liabilities, net of current portion | - | 0 | 0 | 0 |
| Other liabilities | - | 0 | 0 | 0 |
| Total liabilities | 11,056 | 14,519 | 9,849 | 8,756 |
| Common stock, 0.0001 par value 300,000,000 shares authorized 47,196,564 and 47,145,719 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 4 | 4 | 4 | 4 |
| Additional paid-in capital | 491,630 | 489,437 | 487,024 | 484,306 |
| Accumulated other comprehensive (loss) income | -15 | 120 | 139 | 9 |
| Accumulated deficit | -375,444 | -353,250 | -329,999 | -312,253 |
| Total stockholders equity | 116,175 | 136,311 | 157,168 | 172,066 |
| Total liabilities and stockholders equity | 127,231 | 150,830 | 167,017 | 180,822 |
Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. (WHWK)